This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Spironolactone

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Spironolactone is an aldosterone antagonist (also reduces the activity of the enzyme Na+K+ATPase in renal tubular cells (1)) used in the treatment of:

  • oedema and ascites in liver cirrhosis
  • malignant ascites
  • nephrotic syndrome
  • congestive heart failure
  • primary aldosteronism

Contraindications include:

  • hyperkalaemia
  • severe renal impairment
  • pregnancy and breast feeding
  • Addison's disease
  • porphyria

The summary of product characteristics must be consulted before prescribing this drug.

Reference:

  1. Prescriber 2004; 15(9):50-6.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.